DNA Damage/DNA Repair

The DNA in a human cell receives tens of thousands of damages per day due to both external (exogenous) and internal (endogenous) stress. The exogenous damages are caused by chemical contamination, UV light, ionizing radiation and alkylation/methylation etc, while the endogenous damages are coming from oxidation, alkylation and hydrolysis of bases etc. Since single strand and double strand breaks of DNA will occur after the damage, unrepaired DNA damage leads to cell senescent, apoptosis and malignancies etc. To overcome this threat, cell has developed DNA damage response, to detect DNA damage and mediate its repair.
DNA repair involves multiple mechanisms such as mismatch, base excision, and nucleotide excision repair etc. A group of proteins and pathways are participated in those processes. ATM/ATR kinases and DNA-PK are crucial for the detection of the DNA damage. Chromatin remodelers regulate chromatin accessibility for the DNA repair factors to function. RPA, Rad51 and the fanconi anemia proteins act directly on repairing the DNA damage. p53 network, the RAS GTPase superfamily, and the ubiquitin system also play important part in the DNA damage response. Aberrant DNA damage response is linked to aging, cancer and immune diseases.
-   A8337 CX-54612 CitationSummary: Pol I-mediated rRNA synthesis inhibitor A8337 CX-54612 CitationSummary: Pol I-mediated rRNA synthesis inhibitor
-   A8532 TeniposideSummary: Topoisomerase inhibitor A8532 TeniposideSummary: Topoisomerase inhibitor
-   A4104 AR-42 (OSU-HDAC42)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,novel and potent A4104 AR-42 (OSU-HDAC42)2 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC inhibitor,novel and potent
-   A4529 JW 55Summary: PARP domain inhibitor A4529 JW 55Summary: PARP domain inhibitor
-   A5511 OfloxacinTarget: Topoisomerases|DNA gyraseSummary: Fluoroquinolones,antibiotics A5511 OfloxacinTarget: Topoisomerases|DNA gyraseSummary: Fluoroquinolones,antibiotics
-   A8331 Bleomycin Sulfate1 CitationSummary: DNA synthesis inhibitor A8331 Bleomycin Sulfate1 CitationSummary: DNA synthesis inhibitor
-   A4103 LAQ824 (NVP-LAQ824,Dacinostat)1 CitationSummary: HDAC inhibitor,potent and novel A4103 LAQ824 (NVP-LAQ824,Dacinostat)1 CitationSummary: HDAC inhibitor,potent and novel
-   A4528 EB 47Summary: Potent PARP-1 inhibitor A4528 EB 47Summary: Potent PARP-1 inhibitor
-   A5323 Moxifloxacin HCl1 CitationTarget: AntibioticSummary: Fluoroquinolone antibiotic A5323 Moxifloxacin HCl1 CitationTarget: AntibioticSummary: Fluoroquinolone antibiotic
-   A8317 Fludarabine Phosphate (Fludara)2 CitationTarget: STATSummary: Inhibits STAT1 activation and DNA synthesis A8317 Fludarabine Phosphate (Fludara)2 CitationTarget: STATSummary: Inhibits STAT1 activation and DNA synthesis
